Published in J Nucl Med Technol on March 27, 2012
A Pilot Comparison of 18F-fluorocholine PET/CT, Ultrasonography and 123I/99mTc-sestaMIBI Dual-Phase Dual-Isotope Scintigraphy in the Preoperative Localization of Hyperfunctioning Parathyroid Glands in Primary or Secondary Hyperparathyroidism: Influence of Thyroid Anomalies. Medicine (Baltimore) (2015) 0.94
SPECT/CT and tumour imaging. Eur J Nucl Med Mol Imaging (2013) 0.81
Endocrine radionuclide scintigraphy with fusion single photon emission computed tomography/computed tomography. World J Radiol (2016) 0.75
Radio-guided Minimally Invasive Parathyroidectomy: A Descriptive Report of the Experience from Tertiary Center in Bangalore. Indian J Nucl Med (2017) 0.75
Radiologic and nuclear medicine studies in the United States and worldwide: frequency, radiation dose, and comparison with other radiation sources--1950-2007. Radiology (2009) 5.48
Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma. N Engl J Med (2015) 5.44
Renal dosimetry in peptide radionuclide receptor therapy. Cancer Biother Radiopharm (2010) 3.23
Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. J Nucl Med (2006) 3.15
Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: combined data from 4 clinical trials. J Nucl Med (2003) 2.76
FDG PET of infection and inflammation. Radiographics (2005) 2.28
Renal dosimetry: ready for biological effective dose? Cancer Biother Radiopharm (2010) 2.24
Quantification of absolute myocardial perfusion in patients with coronary artery disease: comparison between cardiovascular magnetic resonance and positron emission tomography. J Am Coll Cardiol (2012) 2.15
Radionuclide bone imaging: an illustrative review. Radiographics (2003) 1.89
Bone marrow dosimetry using blood-based models for radiolabeled antibody therapy: a multiinstitutional comparison. J Nucl Med (2004) 1.81
Radioimmunodetection of amyloid deposits in patients with AL amyloidosis. Blood (2010) 1.76
Cyclophosphamide disrupts hepatic sinusoidal endothelium and improves transplanted cell engraftment in rat liver. Hepatology (2002) 1.66
Comparison of (123)I and (131)I for whole-body imaging in thyroid cancer. J Nucl Med (2002) 1.65
SNM practice guideline for sodium 18F-fluoride PET/CT bone scans 1.0. J Nucl Med (2010) 1.63
ACR Appropriateness Criteria® right lower quadrant pain--suspected appendicitis. J Am Coll Radiol (2011) 1.51
First-in-man evaluation of 2 high-affinity PSMA-avid small molecules for imaging prostate cancer. J Nucl Med (2013) 1.51
Gated myocardial perfusion SPECT asynchrony measurements in patients with left bundle branch block. Int J Cardiovasc Imaging (2008) 1.50
Nuclear medicine and the infected joint replacement. Semin Nucl Med (2009) 1.50
Sincalide-stimulated cholescintigraphy: a multicenter investigation to determine optimal infusion methodology and gallbladder ejection fraction normal values. J Nucl Med (2010) 1.48
Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice. J Nucl Med (2003) 1.45
131I ablation treatment in young females after the Chernobyl accident. J Nucl Med (2006) 1.38
Sincalide infusion parameters: key information in a biliary dyskinesia clinical study. Am Surg (2010) 1.38
Kupffer cells participate in early clearance of syngeneic hepatocytes transplanted in the rat liver. Gastroenterology (2002) 1.33
SNM practice guideline for brain death scintigraphy 2.0. J Nucl Med Technol (2012) 1.28
2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging (2009) 1.24
Safety, biodistribution, and dosimetry of 123I-IMPY: a novel amyloid plaque-imaging agent for the diagnosis of Alzheimer's disease. J Nucl Med (2006) 1.22
Attenuation correction in myocardial perfusion SPECT/CT: effects of misregistration and value of reregistration. J Nucl Med (2007) 1.21
Biodistribution and radiation dosimetry of the integrin marker 18F-RGD-K5 determined from whole-body PET/CT in monkeys and humans. J Nucl Med (2012) 1.18
Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging. J Nucl Med (2004) 1.17
Monocrotaline promotes transplanted cell engraftment and advances liver repopulation in rats via liver conditioning. Hepatology (2006) 1.15
Diagnosing infection in the failed joint replacement: a comparison of coincidence detection 18F-FDG and 111In-labeled leukocyte/99mTc-sulfur colloid marrow imaging. J Nucl Med (2004) 1.13
The effect of estrogen-progestin treatment on bone mineral density in anorexia nervosa. J Pediatr Adolesc Gynecol (2002) 1.12
Radionuclide imaging of infection. J Nucl Med Technol (2004) 1.11
Hepatic targeting of transplanted liver sinusoidal endothelial cells in intact mice. Hepatology (2005) 1.11
Changes in radiation dose with variations in human anatomy: larger and smaller normal-stature adults. J Nucl Med (2010) 1.10
Efficacy of preoperative combined 18-fluorodeoxyglucose positron emission tomography and computed tomography for assessing primary rectal cancer response to neoadjuvant therapy. J Gastrointest Surg (2007) 1.09
Exposure rate constants and lead shielding values for over 1,100 radionuclides. Health Phys (2012) 1.08
SNM practice guideline for hepatobiliary scintigraphy 4.0. J Nucl Med Technol (2010) 1.07
Initial evaluation in healthy humans of [18F]DPA-714, a potential PET biomarker for neuroinflammation. Nucl Med Biol (2011) 1.06
Hepatic sinusoidal vasodilators improve transplanted cell engraftment and ameliorate microcirculatory perturbations in the liver. Hepatology (2002) 1.06
SNM practice guideline for lung scintigraphy 4.0. J Nucl Med Technol (2012) 1.06
ACR Appropriateness Criteria pretreatment staging of colorectal cancer. J Am Coll Radiol (2012) 1.05
Effects of extended-release niacin on lipoprotein subclass distribution. Am J Cardiol (2003) 1.04
Changes in radiation dose with variations in human anatomy: moderately and severely obese adults. J Nucl Med (2010) 1.04
SNMMI/ASNC/SCCT guideline for cardiac SPECT/CT and PET/CT 1.0. J Nucl Med (2013) 1.04
Transplantation of bone marrow-derived MSCs improves cisplatinum-induced renal injury through paracrine mechanisms. Exp Mol Pathol (2013) 1.04
FDG-PET staging and importance of lymph node SUV in head and neck cancer. Head Neck Oncol (2010) 1.03
FDG-PET/CT imaging in the management of HIV-associated multicentric Castleman's disease. Eur J Nucl Med Mol Imaging (2008) 1.01
SNM practice guideline for breast scintigraphy with breast-specific gamma-cameras 1.0. J Nucl Med Technol (2010) 1.01
Biodistribution and radiation dosimetry of 11C-WAY100,635 in humans. J Nucl Med (2005) 1.00
Preoperative parathyroid scintigraphic lesion localization: accuracy of various types of readings. Radiology (2008) 0.99
Prosthetic joint infections: radionuclide state-of-the-art imaging. Eur J Nucl Med Mol Imaging (2012) 0.99
Radar commentary: Use of linear no-threshold hypothesis in radiation protection regulation in the United States. Health Phys (2012) 0.99
Expanding role of 18F-fluoro-D-deoxyglucose PET and PET/CT in spinal infections. Eur Spine J (2010) 0.98
Evolution of lower respiratory symptoms in New York police officers after 9/11: a prospective longitudinal study. J Occup Environ Med (2007) 0.97
False-positive bone metastases on PET/CT secondary to sarcoidosis in a patient with rectal cancer. Clin Nucl Med (2012) 0.97
ACR Appropriateness Criteria® Right Lower Quadrant Pain--Suspected Appendicitis. Ultrasound Q (2015) 0.96
Radionuclide imaging of spinal infections. Eur J Nucl Med Mol Imaging (2006) 0.96
18F-FDG PET in pregnancy and fetal radiation dose estimates. J Nucl Med (2011) 0.95
RADAR realistic animal model series for dose assessment. J Nucl Med (2010) 0.95
Normal limits of gated blood pool SPECT count-based regional cardiac function parameters. Int J Cardiovasc Imaging (2008) 0.95
18F-FDG PET versus CT for evaluating the spleen during initial staging of lymphoma. J Nucl Med (2003) 0.94
Regulation of hepatobiliary transport activity and noninvasive identification of cytokine-dependent liver inflammation. J Nucl Med (2005) 0.94
Sestamibi parathyroid scintigraphy in multigland disease. Nucl Med Commun (2012) 0.94
Liver function testing with nuclear medicine techniques is coming of age. Semin Nucl Med (2012) 0.93
Evolution and resolution of human brain perfusion responses to the stress of induced hypoglycemia. Neuroimage (2010) 0.93
Nuclear medicine tests for acute gastrointestinal conditions. Semin Nucl Med (2013) 0.93
PET with FDG-labeled leukocytes versus scintigraphy with 111In-oxine-labeled leukocytes for detection of infection. Radiology (2006) 0.91
SAF values for internal photon emitters calculated for the RPI-P pregnant-female models using Monte Carlo methods. Med Phys (2008) 0.91
Somatostatin-receptor-targeted alpha-emitting 213Bi is therapeutically more effective than beta(-)-emitting 177Lu in human pancreatic adenocarcinoma cells. Nucl Med Biol (2007) 0.91
Increased F-18 FDG uptake in resolving atraumatic bilateral adrenal hemorrhage (hematoma) on PET/CT. Clin Nucl Med (2008) 0.91
In vitro human leukocyte labeling with (64)Cu: an intraindividual comparison with (111)In-oxine and (18)F-FDG. Nucl Med Biol (2009) 0.90
Directly acting drugs prostacyclin or nitroglycerine and endothelin receptor blocker bosentan improve cell engraftment in rodent liver. Hepatology (2013) 0.90
The SNM practice guideline for somatostatin receptor scintigraphy 2.0. J Nucl Med Technol (2011) 0.89
Visualization of brown adipose tissue with 99mTc-methoxyisobutylisonitrile on SPECT/CT. J Nucl Med (2008) 0.88
Functional magnetic resonance cholangiography (fMRC) of the gallbladder and biliary tree with contrast-enhanced magnetic resonance cholangiography. J Magn Reson Imaging (2003) 0.88
Preclinical evaluation of an 131I-labeled benzamide for targeted radiotherapy of metastatic melanoma. Cancer Res (2010) 0.88
Red marrow radiation dose adjustment using plasma FLT3-L cytokine levels: improved correlations between hematologic toxicity and bone marrow dose for radioimmunotherapy patients. J Nucl Med (2003) 0.88
(123)I-mIBG scintigraphy in patients with known or suspected neuroblastoma: Results from a prospective multicenter trial. Pediatr Blood Cancer (2009) 0.87
Kinetic modeling in support of radionuclide dose assessment. Semin Nucl Med (2008) 0.87
Comparative dosimetric evaluation of nanotargeted (188)Re-(DXR)-liposome for internal radiotherapy. Cancer Biother Radiopharm (2008) 0.87
Long-term follow-up of 111In-capromab pendetide (ProstaScint) scan as pretreatment assessment in patients who undergo salvage radiotherapy for rising prostate-specific antigen after radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys (2007) 0.86
Pericatheter leak in a peritoneal dialysis patient: SPECT/CT diagnosis. Clin Nucl Med (2012) 0.86
The relationship between ischemia-induced left ventricular dysfunction, coronary flow reserve, and coronary steal on regadenoson stress-gated (82)Rb PET myocardial perfusion imaging. J Nucl Cardiol (2013) 0.86
Radiation dosimetry and biodistribution of the hypoxia tracer (18)F-EF5 in oncologic patients. Cancer Biother Radiopharm (2012) 0.86
Comment on "Background Ionizing Radiation and the Risk of Childhood Cancer: A Census-Based Nationwide Cohort Study". Environ Health Perspect (2015) 0.86
Correction factors for more accurate estimates of exposure rates near radioactive patients: experimental, point, and line source models. Health Phys (2007) 0.85
Report of satellite workshop on interim-PET in Hodgkin lymphoma: 8th International Symposium on Hodgkin Lymphoma, Cologne, 23 October 2010. Leuk Lymphoma (2011) 0.85
Comparison of FDG-PET/CT and CT for delineation of lumpectomy cavity for partial breast irradiation. Int J Radiat Oncol Biol Phys (2008) 0.85
F-18 FDG versus Ga-67 for detecting splenic involvement in Hodgkin's disease. Clin Nucl Med (2002) 0.85
Sestamibi scans and intraoperative parathyroid hormone measurement in the treatment of primary hyperparathyroidism. Arch Otolaryngol Head Neck Surg (2004) 0.84
Adenosine triphosphate-binding cassette subfamily C member 2 is the major transporter of the hepatobiliary imaging agent (99m)Tc-mebrofenin. J Nucl Med (2009) 0.84
Licensee over-reliance on conservatisms in NRC guidance regarding the release of patients treated with 131I. Health Phys (2007) 0.83
Receptor-binding, biodistribution, dosimetry, and micro-SPECT/CT imaging of 111In-[DTPA(1), Lys(3), Tyr(4)]-bombesin analog in human prostate tumor-bearing mice. Cancer Biother Radiopharm (2009) 0.83
Automated versus manual detection of left ventricular wall motion abnormalities by gated blood pool SPECT. Med Phys (2009) 0.83
ACR Appropriateness Criteria® Suspected upper extremity deep vein thrombosis. J Am Coll Radiol (2012) 0.83
Sentinel Node in Oral Cancer: The Nuclear Medicine Aspects. A Survey from the Sentinel European Node Trial. Clin Nucl Med (2016) 0.82